Suppr超能文献

有心脏手术史的供体是肺移植的可行供体来源。

Donors with a prior history of cardiac surgery are a viable source of lung allografts.

作者信息

Costa Joseph, Sreekanth Sowmyashree, Kossar Alex, Raza Kashif, Robbins Hilary, Shah Lori, Sonett Joshua R, Arcasoy Selim, D'Ovidio Frank

机构信息

Department of Surgery, Division of Cardiac, Vascular and Thoracic Surgery, Columbia University Medical Center, New York, NY, USA.

Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University Medical Center, New York, NY, USA.

出版信息

Eur J Cardiothorac Surg. 2016 Nov;50(5):822-825. doi: 10.1093/ejcts/ezw157. Epub 2016 May 4.

Abstract

OBJECTIVES

End-stage lung disease continues to rise despite the lack of suitable lung donors, limiting the numbers of lung transplants performed each year. Expanded donor criteria, use of donation after cardiac death donors and the advent of ex vivo lung perfusion have resulted only in a slight increase in donor lung utilization. Organ donors with prior cardiac surgery (DPCS) present risks and technical challenges; however, they may be a potential source of suitable lung allografts with an experienced procurement surgeon. We present our experience having evaluated potential lung donors with a prior history of cardiac surgery, resulting in successful transplant outcomes.

METHODS

This is a single-institution retrospective review of brain-dead organ donors that were evaluated for lung donation in the period 2012-15. Donor and recipient characteristics were collected. Post-lung transplant survival was recorded.

RESULTS

From 2012 to 2015, 259 donors were evaluated, 12 with a prior history of cardiac surgery of which 4 had coronary artery bypass, 3 had aortic root replacement, 2 had aortic valve replacement, 1 pulmonary embolectomy, 1 two-time reoperative valve replacement and 1 paediatric congenital ventricular septal defect repair. DPCS, 6/12 (50% dry run) provided suitable allografts generating six single-lung transplants (three right and three left, 1 donor provided twin single-lung transplants) and one double-lung transplant. Interval between cardiac surgery and procurement for those rejected was median 5840 (IQR 2350-8640) days and interval for the donors that provided allografts was median 438 (IQR 336-1095) days (Mann-Whitney, P = 0.07). Recipient 1-year survival from DPCS is 100%. Recipient 1-year survival was 92% in allografts explanted from donors with no prior cardiac surgery (2012-13).

CONCLUSION

To date, this is the largest single-centre experience using lung allografts from brain-dead DPCS. Our experience shows despite predicted technical difficulties, with good communication between thoracic and abdominal teams, successful transplant outcomes are possible, when surgeons with experience in reoperative cases are sent for lung procurements.

摘要

目的

尽管缺乏合适的肺供体,终末期肺病仍持续增加,限制了每年进行的肺移植数量。扩大供体标准、使用心脏死亡后供体以及体外肺灌注技术的出现仅使供肺利用率略有提高。有心脏手术史的器官供体(DPCS)存在风险和技术挑战;然而,对于经验丰富的获取外科医生而言,他们可能是合适肺移植供体的潜在来源。我们介绍了评估有心脏手术史的潜在肺供体的经验,其带来了成功的移植结果。

方法

这是一项单机构回顾性研究,对2012年至2015年期间接受肺移植评估的脑死亡器官供体进行研究。收集供体和受体的特征。记录肺移植后的生存率。

结果

2012年至2015年期间,共评估了259名供体,其中12名有心脏手术史,其中4例接受过冠状动脉搭桥手术,3例接受过主动脉根部置换术,2例接受过主动脉瓣置换术,1例接受过肺动脉栓子切除术,1例接受过二次瓣膜置换手术,1例接受过小儿先天性室间隔缺损修复术。在有心脏手术史的供体中,6/12(50%预试验)提供了合适的移植物,进行了6例单肺移植(3例右肺和3例左肺,1名供体提供了双单肺移植)和1例双肺移植。被拒绝的供体心脏手术与获取之间的间隔时间中位数为5840(四分位间距2350 - 8640)天,提供移植物的供体间隔时间中位数为438(四分位间距336 - 1095)天(曼 - 惠特尼检验,P = 0.07)。有心脏手术史供体的受体1年生存率为100%。在没有心脏手术史的供体(2012 - 13年)的移植物中,受体1年生存率为92%。

结论

迄今为止,这是使用脑死亡有心脏手术史供体的肺移植物的最大单中心经验。我们的经验表明,尽管预计存在技术困难,但通过胸外科和腹部团队之间的良好沟通,当派遣有再次手术经验的外科医生进行肺获取时,成功的移植结果是可能的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验